Skip to main navigation Skip to search Skip to main content

Phase 2 Study of Everolimus Monotherapy in Patients With Nonfunctioning Neuroendocrine Tumors or Pheochromocytomas/Paragangliomas

Research output: Contribution to journalJournal articlepeer-review

Original languageKorean
JournalCancer
StatePublished - 2012.12.15

Cite this